Abstract
THE Friedländer bacillus (Klebsieila pneumoniae) is a relatively rare invader of the central nervous system, but, when encountered, meningitis due to this organism constitutes a major therapeutic problem. Only 119 cases of the infection have been described in the world literature1 since this organism was first described by Friedländer in 1882, and the majority of these cases have appeared in recent years as isolated case reports relating experience with the newer antibiotic agents. A review of these cases reveals that recovery from the infection, virtually nonexistent before the era of specific therapy, has been attributed to the sulfonamides, streptomycin, chlortetracycline . . .